mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.3 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.062 |
0.3 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |